Companies similar to Indaptus Therapeutics, Inc. (INDP)
Health Care · Nasdaq
Indaptus Therapeutics, Inc. (INDP)'s closest peers include Merck & Co. (MRK), Bristol Myers Squibb (BMY), Regeneron Pharmaceuticals (REGN) and NEKTAR THERAPEUTICS (NKTR). This peer set is drawn from INDP's enriched company profile and is informational only — not financial advice.
Similar companies
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
NEKTAR THERAPEUTICSNKTRHealth Care
Clinical-stage immunotherapy company developing regulatory T cell-targeted treatments for autoimmune diseases and cancer.
$67.05 (as of 2026-07-16) · market cap $2.3B
Not quite? Describe exactly what you want →
Peers are drawn from INDP's enriched profile (the same similarity signal the chat uses for "companies like INDP"). See the full profile: Indaptus Therapeutics, Inc. (INDP).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.